These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9423304)

  • 41. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of urinary macromolecules on the crystallization of calcium oxalate.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1990; 18(6):381-5. PubMed ID: 2100412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sialic acid concentrations in the urine of men with and without renal stones.
    van Aswegen CH; van der Merwe CA; du Plessis DJ
    Urol Res; 1990; 18(1):29-33. PubMed ID: 2316070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study.
    Pourmand G; Nasseh H; Sarrafnejad A; Mojtahedi A; Mehrsai A; Alamdari DH; Nourijelyani K
    Urol Int; 2006; 76(2):163-8. PubMed ID: 16493220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural and functional modification of THP on nitration: comparison with stone formers THP.
    Pragasam V; Kalaiselvi P; Subashini B; Sumitra K; Varalakshmi P
    Nephron Physiol; 2005; 99(1):p28-34. PubMed ID: 15637470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
    Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
    BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of urinary zinc and copper on calcium oxalate stone formation.
    Ozgurtas T; Yakut G; Gulec M; Serdar M; Kutluay T
    Urol Int; 2004; 72(3):233-6. PubMed ID: 15084769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model system.
    Marangella M; Daniele PG; Ronzani M; Sonego S; Linari F
    Urol Res; 1985; 13(4):189-93. PubMed ID: 4049606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.